about
Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitisAdditive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-studyOccupation-related differences in the prevalence of metabolic syndromePlasmapheresis as treatment for hyperlipidemic pancreatitis.[Cancer and cardiovascular disease].Atorvastatin in dyslipidaemia of the nephrotic syndrome.Association of moderate and severe hypertriglyceridemia with obesity, diabetes mellitus and vascular disease in the Spanish working population: results of the ICARIA study.Exploring the value of apoB48 as a marker for atherosclerosis in clinical practice.Association of the -250G/A promoter polymorphism of the hepatic lipase gene with the risk of peripheral arterial disease in type 2 diabetic patients.Localized rheumatoid vasculitis presenting as acute alithiasic cholecystitis.Higher red blood cell distribution width is associated with the metabolic syndrome: results of the Ibermutuamur CArdiovascular RIsk assessment study.Peripheral arterial disease in HIV patients older than 50 years of age.Prevalence of atherogenic dyslipidemia: association with risk factors and cardiovascular risk in Spanish working population. "ICARIA" study.Effect of apolipoprotein C3 and apolipoprotein A1 polymorphisms on postprandial response to a fat overload in metabolic syndrome patients.Postprandial apolipoprotein B48 is associated with asymptomatic peripheral arterial disease: a study in patients with type 2 diabetes and controls.Smoking and postprandial triglycerides are associated with vascular disease in patients with type 2 diabetes.Factors influencing return-to-work after cerebrovascular disease: the importance of previous cardiovascular risk.Clinical decisions in patients with diabetes and other cardiovascular risk factors. A statement of the Spanish Society of Internal MedicineAssessment of Ga-PSMA-11 PET positivity predictive factors in prostate cancerCOSMIC project: consensus on the objectives of the metabolic syndrome in clinicEndogenous Calcification Inhibitors in the Prevention of Vascular Calcification: A Consensus Statement From the COST Action EuroSoftCalcNetInternal Carotid Artery Hypoplasia: A New Clinical Feature in Pseudoxanthoma ElasticumLipids and lipoproteins in cord blood: analyses of a Hispanic and Arab populationApolipoprotein distribution in plasma HDL subfractions in alcohol consumersShort-term lipid changes associated with highly active antiretroviral therapy in naive HIV-infected patients[Value of the ankle-brachial index in cardiovascular risk stratification of patients without known atherotrombotic disease. MERITO study]Parameters of oxidative stress are present in the circulation of PXE patients[Usefulness of the ankle-arm index for detection of peripheral arterial disease in a working population of Junta de Andalucía at Málaga]Triglyceride levels and apolipoprotein E polymorphism in patients with acute pancreatitisComment on ESH position paper: renal denervation--an interventional therapy of resistant hypertension[Hypertriglyceridemia and LMF 1: Another piece of the puzzle][Homozygous familial hypercholesterolaemia: Spanish adaptation of the position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Consensus document of the Spanish Society of Arteriosclerosis (SHigh risk of subclinical atherosclerosis in COPD exacerbator phenotypeOverall Mortality and LDL Cholesterol Reduction in Secondary Prevention Trials of Cardiovascular DiseaseGenetic variants in the LPL and GPIHBP1 genes, in patients with severe hypertriglyceridaemia, detected with high resolution melting analysisClinical and genetic differences between heterozygous familial hypercholesterolemia patients with and without type 2 diabetesMolecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society18FDG PET/CT & arterial inflammation: predicting cardiovascular events in lung cancerSubclinical Arteriosclerosis is Associated With Common Vascular Risk Factors in Long-Term Survivors of Testicular CancerDocument of recommendations of the SEA 2018. Lifestyle in cardiovascular prevention
P50
Q33470002-5057D9DD-AD87-4C88-A9F1-67B4FC853DC3Q33568117-B0642BE7-D543-4250-8495-CB86E2DA1ADFQ36842123-0822ED6E-9235-412D-B562-BBBA8563BCD0Q38135108-65126468-055A-4359-8C4E-56B55964B059Q43448959-D97BA856-8D84-46E2-BC87-6C29D2257FACQ44794124-8EB3A378-9EE0-43D0-8579-D76153CE7B25Q45958359-E0594805-6D3B-469D-A911-5E74FB34C30FQ46055519-66998125-75D7-415D-A89D-2E50B2245B6AQ46644190-AE564E2F-246A-46B4-808A-BB2259FE62C7Q50177185-B35F824C-8656-4FA4-8E03-FCF91536B64CQ50584044-4FA3CF68-47F3-46DE-899B-AA106DDB9E05Q51119256-A8C0050F-F753-4383-8E3A-A8A2894C4BF0Q51132438-D5ADD5FB-CF27-47E8-8F40-8BDAD9B9D30EQ51392730-D5C4455E-D6FC-40F7-9F3E-E27A365E15B9Q51408672-0CCC12FE-6609-4200-8910-7554EEE2183EQ51489206-DBB2F0E1-A331-434D-9132-E18910D4275DQ51809941-806FBA87-BA4F-449F-AFDE-86F1A5DDDE35Q57212357-593AE81B-AF73-41AC-93A1-8DB45363F06AQ58599630-8FFFA504-3EFA-456F-84B9-56AA17C29E43Q59125991-B0F82EF0-53DF-4BF6-A2CD-A4CB9C8293FBQ61813239-71510D6C-9FC2-4979-99F4-D2107E5A36F7Q64238881-B5FF1085-764D-44D0-B252-1D0025279CA4Q68009920-0CE84DF0-0EC8-4EF9-8060-38EE9C5598B0Q68606732-63B8F0A8-5470-4A1C-B687-62B0BB204100Q79117571-023C55B7-3113-4988-8C78-4C1A08E27016Q79867414-A43BF6BE-99EE-43E0-8F07-71CF1D49740FQ81362621-94E217CD-4EA2-40F6-9B06-85C236D669E4Q83250069-697EF89F-0190-4C10-810F-A2F364FEFBCFQ83260416-B8495BA1-16D7-4255-909F-3B469AF038FAQ85435467-CEFB01C8-9270-4816-8484-BFCCD7984AFDQ86232950-9E263B9E-DE21-43AC-B041-9D78D3354E3BQ86900125-72E5422A-7071-43C0-A366-7F9820494675Q90576807-9A46CA01-697A-451A-8A20-3CC5AA717998Q90935331-8918A22C-53E6-4BC5-A1BB-12D123CD22D7Q91029273-947A615E-0D65-418A-8D35-443F21A1D09BQ91042743-CF524759-F4F3-4944-B3B5-82342BD86717Q91163914-B0D012FB-0AF9-44E8-8E61-6FE424E2475BQ91330264-27C365AA-420C-4365-B3AC-6FFE5649EE26Q91542129-72DC5857-714C-4FE1-90CD-0141D1A67BE8Q91591000-A555953A-5D35-4F79-A92F-645EF8A8E39A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pedro Valdivielso
@ast
Pedro Valdivielso
@en
Pedro Valdivielso
@es
Pedro Valdivielso
@nl
Pedro Valdivielso
@sl
type
label
Pedro Valdivielso
@ast
Pedro Valdivielso
@en
Pedro Valdivielso
@es
Pedro Valdivielso
@nl
Pedro Valdivielso
@sl
prefLabel
Pedro Valdivielso
@ast
Pedro Valdivielso
@en
Pedro Valdivielso
@es
Pedro Valdivielso
@nl
Pedro Valdivielso
@sl
P1053
E-7338-2014
P106
P21
P31
P3829
P496
0000-0003-4458-9833